Abstract:Quantifying microbleeds' susceptibility and size using QSM derived from MPRAGE was evaluated using in vivo and simulated measurements, in comparison with standard multiecho QSM. Results showed that the detection sensitivity of MPRAGE‐QSM was comparable with standard QSM. MPRAGE‐QSM provides an opportunity to detect and quantify the size and susceptibility of microbleeds of at least one‐voxel diameter at B0 ≥ 3 T with no additional time cost, when standard T2*w images are not available or have inadequate spatial resolution. T1‐weighted magnetization‐prepared rapid gradient‐echo (MPRAGE) is commonly included in brain studies for structural imaging using magnitude images; however, its phase images can provide an opportunity to assess microbleed burden using quantitative susceptibility mapping (QSM). This potential application for MPRAGE‐based QSM was evaluated using in vivo and simulated measurements. Possible factors affecting image quality were also explored. Detection sensitivity was evaluated against standard multiecho gradient echo (MEGE) QSM using 3‐T in vivo data of 15 subjects with a combined total of 108 confirmed microbleeds. The two methods were compared based on the microbleed size and susceptibility measurements. In addition, simulations explored the detection sensitivity of MPRAGE‐QSM at different representative magnetic field strengths and echo times using microbleeds of different size, susceptibility, and location. Results showed that in vivo microbleeds appeared to be smaller (× 0.54) and of higher mean susceptibility (× 1.9) on MPRAGE‐QSM than on MEGE‐QSM, but total susceptibility estimates were in closer agreement (slope: 0.97, r2: 0.94), and detection sensitivity was comparable. In simulations, QSM at 1.5 T had a low contrast‐to‐noise ratio that obscured the detection of many microbleeds. Signal‐to‐noise ratio (SNR) levels at 3 T and above resulted in better contrast and increased detection. The detection rates for microbleeds of minimum one‐voxel diameter and 0.4‐ppm susceptibility were 0.55, 0.80, and 0.88 at SNR levels of 1.5, 3, and 7 T, respectively. Size and total susceptibility estimates were more consistent than mean susceptibility estimates, which showed size‐dependent underestimation. MPRAGE‐QSM provides an opportunity to detect and quantify the size and susceptibility of microbleeds of at least one‐voxel diameter at B0 of 3 T or higher with no additional time cost, when standard T2*‐weighted images are not available or have inadequate spatial resolution. The total susceptibility measure is more robust against sequence variations and might allow combining data from different protocols.

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping.

Quantifying cerebral microbleeds using quantitative susceptibility mapping from magnetization‐prepared rapid gradient‐echo

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.

Differentiating calcifications from cerebral microbleeds using quantitative susceptibility mapping

Clinical Feasibility of Brain Quantitative Susceptibility Mapping.

Clinical Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in Essential Hypertension

CSF Susceptibility Variation in Patient With Intracranial Hemorrhage: Implications for Quantitative Susceptibility Mapping Reference Selection

Quantitative Susceptibility Mapping As a Biomarker for Evaluating White Matter Alterations in Parkinson's Disease.

Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study

Characterization of Quantitative Susceptibility Mapping in the Left Ventricle of the Myocardium

Enhanced Reader Confidence and Differentiation of Calcification from Cerebral Microbleed Diagnosis Using QSM Relative to SWI

Value of Multiple Sequences at 3.0T Magnetic Resonance Imaging for Diagnosis of Cerebral Microbleeds

Investigating Microbleeding in Cerebral Ischemia Rats Using Susceptibility-Weighted Imaging

Combining Quantitative Susceptibility Mapping With the Gray Matter Volume to Predict Neurological Deficits in Patients With Small Artery Occlusion

Research progress and clinical applications of quantitative susceptibility mapping

Detection of Cerebral Microbleeding by Susceptibility Weighted Imaging Sequence and Research on Relation Between CMBs and Risk Factors

Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping.

A method for estimating and removing streaking artifacts in quantitative susceptibility mapping